Home > Drug List > Nintedanib > News of Nintedanib

News of Nintedanib

This drug was first approved for marketing in the United States in 2014 and is now widely used in the clinical treatment of various pulmonary fibrosis diseases.

Nintedanib

Nintedanib

Indications： It is indicated for the treatment of idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung disease (ILD), and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in ad

Scan code
Whatsapp

Medicine-related columns

Recommended Articles

Related Articles

There is no data under this category！
Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More

Hospital Departments
Latest Articles
Medicine Updates

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.

Product

Product

Contact US

Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos

E-mail:laoslucius@gmail.com

Whatsapp:

ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved

whatsapp